RxSight, Inc.
Health
Performance
8.7
Risk
Sell
Buy
Curious about the Scores? Learn more.

RxSight, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

23.12.2025
Momentum tanked. Clearly underperforming.
10.12.2025
Red alert. Risk levels out of control.
RXST
RxSight, Inc.
5.40
+2.85%
8.7
Sell
Buy
RxSight, Inc.

RxSight, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does RxSight, Inc. do? Business model and key facts

Get the full picture of RxSight, Inc.: what it builds, where it operates, and how it makes money.

RxSight, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 461

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.

shop
Company facts
Ronald Kurtz
CEO
461
Employees worldwide
shop
Performance
-28.57%
Last 12 months
-67.19%
Last 5 years
shop
Growth
$134.48M
Revenue year
$-38,944,000
Net income
shop
Valuation
$229.75M
Market Cap
-10.97
Price/Earnings Ratio

Stocks related to RxSight, Inc.

Selected based on industry alignment and relative market positioning.

TMCI
Treace Medical Concepts, Inc.
4.08
-3.66%
9.4
Sell
Buy
Treace Medical Concepts, Inc.
VREX
Varex Imaging Corporation
10.69
-0.33%
7.2
Sell
Buy
Varex Imaging Corporation
PACB
Pacific Biosciences of California, Inc.
1.40
-0.36%
8.6
Sell
Buy
Pacific Biosciences of California, Inc.
ANIK
Anika Therapeutics, Inc.
15.30
+0.92%
4.8
Sell
Buy
Anika Therapeutics, Inc.
QTRX
Quanterix Corporation
3.87
-2.52%
9.0
Sell
Buy
Quanterix Corporation

Events and news impacting RxSight, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

RxSight, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.